| 03-09-10 |
Gezamenlijk persbericht namens Directie, Ondernemingsraad en Raad van Commissarissen MSD/N.V. Organon/Organon BioSciences>> |
| 03-09-10 |
Nucletron appoints new Executive Vice President, Global Sales and Service>> |
| 02-09-10 |
Oprichter Pepscan gehuldigd bij afscheid>> |
| 02-09-10 |
6th Dutch Life Sciences & Health Conference, on December 8, 2010>> |
| 02-09-10 |
Pharming Clears 2010 Private Bond Debt>> |
| 01-09-10 |
Qiagen Launches New Automated Modular Testing Platform for Molecular Diagnostics>> |
| 31-08-10 |
DOSSIER MSD : News update MSD - week 34>> |
| 31-08-10 |
Amsterdam Molecular Therapeutics Reports Half-Year Results 2010>> |
| 30-08-10 |
Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science>> |
| 28-08-10 |
Philips introduces newly enhanced cardiac ultrasound system>> |
| 27-08-10 |
Arcarios B.V. announces closing of financing round >> |
| 25-08-10 |
Pharming Plans Submission Rhucin BLA To Us FDA End 2010>> |
| 25-08-10 |
DSM Biomedical Announces Six New License Agreements with Orthopedic, Cardiovascular, Vascular and Urology Device Manufacturers >> |
| 25-08-10 |
Pharming Provides Update On Outstanding Shares>> |
| 24-08-10 |
DOSSIER MSD : News update MSD - week 33>> |
| 23-08-10 |
LSH zoekt Webmaster (3 dgn per week)>> |
| 23-08-10 |
ProFibrix to Present Phase II Data at International Fibrinogen Workshop in Rotterdam, the Netherlands>> |
| 23-08-10 |
FDA grants Orphan Drug Status for to-BBB’s lead product>> |
| 20-08-10 |
Philips adds to its healthcare lighting portfolio with the acquisition of Burton>> |
| 20-08-10 |
Scientists Pinpoint Earliest Steps of Common Form of Muscular Dystrophy>> |
| 19-08-10 |
Pharming’s Supervisory Board Nominates CFO>> |
| 18-08-10 |
AMT's Marketing Authorisation Application for Glybera(R) Progressing on Schedule>> |
| 18-08-10 |
Pharming Provides Update On Outstanding Shares>> |
| 17-08-10 |
BACKGROUND: Sharing of Data Leads to Progress on Alzheimer’s >> |
| 17-08-10 |
Crucell Reports Record Revenues in Second Quarter 2010>> |
| 17-08-10 |
Philips joins new venture capital fund to foster innovation in healthcare>> |
| 17-08-10 |
BAC and Octapharma extend collaboration for G-CSF custom ligand for commercial scale manufacture>> |
| 16-08-10 |
DOSSIER MSD : News update MSD - week 32>> |
| 13-08-10 |
KP7 Health call 2011 gepubliceerd>> |
| 13-08-10 |
Crucell to Release Second Quarter 2010 Results on Tuesday August 17, 2010>> |
| 13-08-10 |
6th EuroTransBio (ETB) Call open for submissions>> |
| 11-08-10 |
Epson Partners With Philips to Offer Printing Solutions for Ultrasound Medical Devices Worldwide>> |
| 11-08-10 |
Versterking kenniseconomie vraagt scherpere keuzes>> |
| 11-08-10 |
Crucell and Harvard (BIDMC) Join Forces with IAVI to Advance AdVac®-based AIDS Vaccine>> |
| 10-08-10 |
Philips-banen voor ontslagen MSD-medewerkers>> |
| 10-08-10 |
Qiagen Reports Solid Second Quarter 2010 Results>> |
| 10-08-10 |
AMT Nominates Three High Profile Executives to Supervisory Board and Expands Management Team With Director Regulatory Affairs and Senior Clinical Consultant>> |
| 09-08-10 |
Bent u een succesvolle MKB ondernemer?>> |
| 06-08-10 |
Galapagos half year results in line with full year guidance >> |
| 06-08-10 |
Galapagos initiates Phase I study for JAK inhibitor GLPG0634, acquires full rights to compound from GSK >> |
| 06-08-10 |
Pharming Provides Update On Outstanding Shares>> |
| 06-08-10 |
OctoPlus announces 2010 first half-year results>> |
| 05-08-10 |
Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine>> |
| 05-08-10 |
KP7: € 6,4 miljard voor slimme groei en slimme banen>> |
| 04-08-10 |
Statement MSD>> |
| 04-08-10 |
New Director Marketing & Sales for Kreatech Diagnostics>> |
| 03-08-10 |
Webcast of Qiagen N.V.'s (Nasdaq: QGEN) Second Quarter 2010 Financial Results Call Set for August 10>> |
| 03-08-10 |
DSM delivers very strong Q2 results as transformation progresses >> |
| 02-08-10 |
Philips continues to expand its clinical informatics portfolio with the acquisition of CDP business>> |
| 02-08-10 |
European Inventor Award 2011 op zoek naar de beste uitvinders van Europa>> |
| 30-07-10 |
SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials >> |
| 29-07-10 |
Philips further expands healthcare business in emerging markets by acquiring ultrasound equipment firm Shanghai Apex Electronics>> |
| 29-07-10 |
Europees-Indiase samenwerking gaat van start>> |
| 27-07-10 |
QPS Announces the Acquisition of Xendo Drug Development>> |
| 27-07-10 |
Sanofi-aventis and Merck Appoint Raul Kohan as CEO for the New Animal Health Joint Venture >> |
| 23-07-10 |
Philips and Dako join forces in digital pathology>> |
| 22-07-10 |
Kreatech Diagnostics signs exclusive license deal>> |
| 21-07-10 |
Taskforce gaat aan de slag met Life Sciences Park in Oss>> |
| 21-07-10 |
Release of Nucletron Oncentra v4.0 Offers Innovations for Brachytherapy and External Beam Treatment Planning >> |
| 21-07-10 |
Pharming Publishes Financial Report First Half Year 2010>> |
| 21-07-10 |
Moleculaire netwerken in het brein en antennes van de cel in een computermodel>> |
| 20-07-10 |
Kamer kritisch over inzet voor Organon>> |
| 20-07-10 |
Philips' Second Quarter and Semi-Annual Results 2010>> |
| 20-07-10 |
UMC's gaan mega-shoppen>> |
| 20-07-10 |
Biogen Idec and Swedish Orphan Biovitrum present data on long-lasting hemophilia B therapy at the World Federation of Hemophilia Congress>> |
| 20-07-10 |
European Medicines Agency launches new website>> |
| 20-07-10 |
Pharming Completes Spin-off Of DNage>> |
| 20-07-10 |
Pharmaceutical company IQ Therapeutics discovers effective treatment against anthrax>> |
| 16-07-10 |
First two ODD-support grants awarded to DNage and to-BBB technologies>> |
| 16-07-10 |
Galapagos and University of Bristol enter drug discovery collaboration in chronic pain >> |
| 16-07-10 |
Agendia to provide testimony at public meeting on FDA oversight of laboratory-developed tests>> |
| 15-07-10 |
Farmaciepersoneel MSD voert actie>> |
| 13-07-10 |
Crucell Reaches Agreement with Sanofi Pasteur on Programs in the Field of Paediatric and Respiratory Vaccines>> |
| 13-07-10 |
Pharming Provides Update On Outstanding Shares>> |
| 13-07-10 |
Study from First Latin American Country to Implement National HPV Testing Program Shows Successful Cervical Cancer Control>> |
| 12-07-10 |
OctoPlus signs drug development contact with The Medicines Company>> |
| 12-07-10 |
NIH extends agreement with Galapagos until end 2012>> |
| 09-07-10 |
Innocore and Nanomi strengthen collaboration>> |
| 09-07-10 |
Qiagen Appoints Chief Medical Officer>> |
| 09-07-10 |
MSD kondigt herstructurering van de locatie in Oss aan in het kader van wereldwijde integratie na de fusie tussen Merck en Schering-Plough >> |
| 09-07-10 |
InteRNA Technologies announces establishment of Scientific Advisory Board>> |
| 08-07-10 |
arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform>> |
| 08-07-10 |
Kiadis Pharma receives IND approval from FDA to start pivotal clinical trial with ATIR™>> |
| 07-07-10 |
Qiagen Announces CE Marking of its careHPV Test for Developing Countries>> |
| 07-07-10 |
Pharming And Sanofi Chimie Sign Manufacturing Agreement For The Drug Substance Of Ruconest™>> |
| 06-07-10 |
Afronding verkoop allergiedivisie door Fornix aan Alkabello>> |
| 06-07-10 |
Nationaal Kinderoncologisch Centrum komt in Amsterdam>> |
| 05-07-10 |
PSR Launches New Service for Companies Planning Orphan Drug Development, OrphanIQ>> |
| 05-07-10 |
Lance Armstrong vervult droom patiënten in Daniel den Hoed>> |
| 02-07-10 |
Onderzoekstalent maakt kans op LUMC Research Fellowship>> |
| 02-07-10 |
750.000 euro voor diabetesonderzoek>> |
| 01-07-10 |
Skyline Diagnostics closes licensing agreement>> |
| 01-07-10 |
Servier and Galapagos initiate strategic alliance in osteoarthritis>> |
| 30-06-10 |
Brede kennis en innovatie coalitie presenteert actieplan>> |
| 30-06-10 |
Reactie op media-aandacht inzake MSD Oss>> |
| 30-06-10 |
Pharming Provides Update On Outstanding Shares>> |
| 30-06-10 |
Galapagos correction: transparency notification>> |
| 30-06-10 |
OctoPlus announces agreement with a major pharmaceutical company on its controlled release technology>> |
| 29-06-10 |
Fornix shareholders approve sale of Allergy division>> |
| 29-06-10 |
Qiagen Wins 2010 Mediscience Award for “Transaction of the Year”>> |
| 29-06-10 |
Frankfurt To Host World's Largest Pharmaceutical Services Events In 2011>> |
| 28-06-10 |
Galapagos increases share capital through warrant exercises, receives transparency notifications>> |
| 25-06-10 |
ABP en OMERS lanceren investeringsprogramma INKEF Capital>> |
| 25-06-10 |
Pharming Receives Positive Opinion From European Medicines Agency On Rhucin>> |
| 24-06-10 |
Prosensa and GlaxoSmithKline initiate development of four additional products under existing alliance in Duchenne Muscular Dystrophy.>> |
| 24-06-10 |
China Pharma Events Attract Record Attendance>> |
| 24-06-10 |
Philipp Heretsch wins first prize in DSM Science & Technology Awards (South) 2010 >> |
| 24-06-10 |
Crucell Announces Start of Universal RSV Vaccine Program>> |
| 24-06-10 |
Bio artificial cornea research may bring light to the blind >> |
| 23-06-10 |
OncoMethylome Sciences Shareholder Notification>> |
| 22-06-10 |
European drug companies lead 'access to medicine index'>> |
| 21-06-10 |
Merus Announces Publication of the Generation of Single, Clonal Cell lines>> |
| 21-06-10 |
Pharming Provides Update On Outstanding Shares>> |
| 20-06-10 |
Mymetics’ Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania >> |
| 18-06-10 |
Apax shareholding in Galapagos placed with institutional investors>> |
| 17-06-10 |
ProFibrix and CSL Behring Enter into Fibrinogen and Thrombin Supply Agreement>> |
| 17-06-10 |
Qiagen Expands Partnership with Genome Diagnostics>> |
| 17-06-10 |
Agendia bekijkt vertrek naar VS wegens 'treurig innovatiebeleid'>> |
| 16-06-10 |
Survival rate up to 100% for late stage treatment of Anthrax infections>> |
| 16-06-10 |
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions>> |
| 16-06-10 |
Philips demonstrates on-going commitment to nationwide healthcare infrastructure modernization in the Republic of Zambia>> |
| 16-06-10 |
Genmab announces Change in Management >> |
| 16-06-10 |
GlaxoSmithKline: steunbetuiging aan Top Instituut Pharma >> |
| 16-06-10 |
Wensenlijst en aanbod bij kabinetsformateur >> |
| 15-06-10 |
Pharming Provides Background Information On Recently Completed Private Offering>> |
| 14-06-10 |
to-BBB receives positive opinion for Orphan Drug Designation >> |
| 13-06-10 |
Winnaar Inventor Award: Sanquin i.s.m. NKI>> |
| 11-06-10 |
FDA advisory committee unanimously recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS>> |
| 11-06-10 |
Willem de Vos is Nederlands Meest Ondernemende Wetenschapper van 2010>> |
| 10-06-10 |
Philips CEO updates market on implementation of strategy to become the leading company in health and well-being>> |
| 10-06-10 |
BMEYE B.V. Selected as a Red Herring Top 100 Europe Technology Startup>> |
| 09-06-10 |
Bachem (SIX: BANB) and ISA Pharmaceuticals>> |
| 07-06-10 |
Qiagen HPV DNA test donation to expand access to cervical cancer screening for women in rural India>> |
| 07-06-10 |
Crucell 2010 Annual General Meeting of Shareholders 2009 Financial Statements Adopted; All Resolutions Approved>> |
| 07-06-10 |
Philips and RXi Pharmaceuticals sign agreement to jointly research innovative image-guided therapy concepts based on RNAi>> |
| 04-06-10 |
Scientists give go-ahead for private storage >> |
| 04-06-10 |
Amsterdam Molecular Therapeutics Reports Positive New Clinical Data from Glybera® Study >> |
| 03-06-10 |
DiagnOptics receives ISO 13485 certification. >> |
| 03-06-10 |
KWF Kankerbestrijding investeert miljoenen in kinderkanker>> |
| 02-06-10 |
Bachem to supply ISA Pharmaceuticals with finished dosage forms immunotherapeutic HPV-SLP® for phase III clinical trials>> |
| 02-06-10 |
Bachem to supply ISA Pharmaceuticals with finished dosage forms immunotherapeutic HPV-SLP for phase III clinical trials >> |
| 02-06-10 |
Missie Top Institute Pharma in gevaar>> |
| 01-06-10 |
Achmea vergoedt test voor borstkanker>> |
| 01-06-10 |
New clinical study shows telehealth patients experience a significant improvement in care and quality of life>> |
| 31-05-10 |
Syntarga Announces Additional Antibody-Drug Conjugate Collaborations>> |
| 31-05-10 |
OncoMethylome shareholders pass all resolutions at AGM and appoint three new independent directors>> |
| 31-05-10 |
Mucosis Receives Financial Support from the Dutch Government for Its Flugem Program>> |
| 31-05-10 |
NIH-subsidie voor spierziekte FSHD>> |
| 28-05-10 |
80 miljoen voor samenwerking bedrijven en kennisinstellingen>> |
| 28-05-10 |
Cavadis announced today the successful completion of its Series A financing round.>> |
| 28-05-10 |
Pharming Reports On Shareholders Meeting>> |
| 27-05-10 |
PHARMING INITIATES EQUITY FUNDRAISING>> |
| 27-05-10 |
Nucletron reports all time high EBITDA in 2009 >> |
| 27-05-10 |
Qiagen and Roche settle dispute over distribution agreement for TheraScreen companion diagnostics>> |
| 26-05-10 |
Philips launches award program to improve health and well-being of people living in cities>> |
| 26-05-10 |
First coronary stent on drug eluting balloon implanted>> |
| 25-05-10 |
Galapagos achieves milestones in osteoporosis alliance >> |
| 25-05-10 |
Pharming Submits D180 Response For Rhucin MAA To EMA Without Clock Stop>> |
| 24-05-10 |
Launch of innovative Cryo-Lip® stem cell storage service for liposuction market>> |
| 24-05-10 |
DCTF Jaarcongres 2010>> |
| 21-05-10 |
Amsterdam Molecular Therapeutics Reports Promising Data from Cholesterol Lowering Gene Therapy Study>> |
| 21-05-10 |
Pharming Receives D180 List Of Outstanding Issues On Rhucin MAA>> |
| 21-05-10 |
to-BBB announces brain drug delivery pilot study with Janssen Pharmaceutica NV for CNS diseases>> |
| 21-05-10 |
DSM Dyneema Launches Dyneema Purity® BLUE, the World’s First Implantable Medical Grade UHMWPE Fiber in Color >> |
| 21-05-10 |
Slimme ‘chemo-bommen’ bestrijden kanker gerichter>> |
| 20-05-10 |
Philips announces major new ASEAN health and well-being study from 3rd ASEAN Symposium on access to healthcare>> |
| 20-05-10 |
The French Competition Authority Follows up Allegations of Anti-competitive Practices by Sanofi-Aventis to Exclude Fair Generic Competition for Plavix(R) (clopidogrel) >> |
| 20-05-10 |
AMT Provides Business Update for the First Quarter 2010 >> |
| 20-05-10 |
Galapagos initiates clinical studies with GLPG0492, a candidate drug for cachexia >> |
| 19-05-10 |
Philips and Electron announce partnership for development and production of Healthcare products in Russia>> |
| 19-05-10 |
OctoPlus publishes first quarter business update>> |
| 18-05-10 |
Philips CEO updates market on implementation of strategy to become the leading company in health & well-being>> |
| 18-05-10 |
Gilde Healthcare II sells its stake in FlowCardia>> |
| 18-05-10 |
WIL Research appoints David Spaight as chief executive officer>> |
| 18-05-10 |
Nederland fiscaal aantrekkelijk voor buitenlandse bedrijven>> |
| 17-05-10 |
Pharming Initiates Divestment Of DNage>> |
| 17-05-10 |
Merck and Cardiome Announce Phase III Study Results Comparing Investigational Compound BRINAVESSTM (Vernakalant) Intravenous to Amiodarone Injection in Conversion of Atrial Fibrillation to Normal Sinus Rhythm>> |
| 17-05-10 |
Pharming Provides Update On Outstanding Shares>> |
| 14-05-10 |
Galapagos business update>> |
| 12-05-10 |
Shareholders OctoPlus appoint Susan Swarte to Executive Board and Nancy de Ruiter to Supervisory Board>> |
| 11-05-10 |
First Brachytherapy Rome Event Signifies Importance of Precision Cancer Treatment>> |
| 11-05-10 |
Galapagos and Roche expand COPD alliance>> |
| 11-05-10 |
Crucell Announces First Quarter 2010 Results>> |
| 11-05-10 |
Crucell and NIH Announce Start of Malaria Vaccine Trial in Burkina Faso>> |
| 07-05-10 |
Fornix publishes trading update for first four months of 2010>> |
| 07-05-10 |
Philips updates markets on Healthcare sector in meeting with investors and financial analysts>> |
| 06-05-10 |
OncoMethylome's Q1 2010 Business Update>> |
| 06-05-10 |
Professor Sander van Deventer appointed to Supervisory Board of AMT>> |
| 06-05-10 |
Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem® by UNICEF to Support Vaccination Programs in the Developing World>> |
| 06-05-10 |
Extra belastingvoordeel via de Innovatiebox>> |
| 05-05-10 |
Crucell to Release First Quarter 2010 Results on Tuesday May 11, 2010 >> |
| 04-05-10 |
Gene for Schinzel-Giedion syndrome rapidly found>> |
| 04-05-10 |
Merck Announces First-Quarter 2010 Financial Results>> |
| 04-05-10 |
Qiagen Reports Strong First Quarter 2010 Results>> |
| 04-05-10 |
Dutch Top Institute invests in young talented biomedical materials researchers >> |
| 03-05-10 |
SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies >> |
| 03-05-10 |
OncoMethylome Presents Promising Results of Colorectal Cancer Screening Program at Digestive Disease Week Conference>> |
| 03-05-10 |
DSM Biologics Announces Entering an Agreement with the Australian Governments to Build and Operate a Biopharmaceutical Manufacturing Facility in Brisbane>> |
| 01-05-10 |
IQ Products and IBL International close deal>> |
| 30-04-10 |
New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy>> |
| 30-04-10 |
DSM Biomedical Expands Portfolio Offering for Ophthalmic Market>> |
| 29-04-10 |
Merck Announces Senior Management Appointments>> |
| 29-04-10 |
Galapagos and CHDI Foundation, Inc. enter new five-year collaboration for Huntington's disease therapeutics>> |
| 28-04-10 |
Pepscan signs partnering agreement with Immunovo for its therapeutic vaccine portfolio>> |
| 28-04-10 |
Mucosis appoints Dr. Roberto Grimandi as chief medical officer>> |
| 28-04-10 |
Kiadis Pharma Provides ATIR Update>> |
| 28-04-10 |
DSM reports very strong start to 2010 in an improved business environment>> |
| 28-04-10 |
Galapagos announces appointment of Ronald Brus to Board; creates new warrant plans>> |
| 28-04-10 |
Synthon Receives Final Approval for Tamsulosin, AB-rated to Flomax>> |
| 27-04-10 |
Immunovo BV- A New Biotechnology Company is Announced >> |
| 26-04-10 |
Fornix kondigt aan voornemens te zijn haar Nederlandse Allergiedivisie te verkopen aan ALK-Abello voor een koopprijs van EUR 19,6 miljoen in contanten>> |
| 26-04-10 |
Gratis workshops WBSO voor innovatieve ondernemers>> |
| 26-04-10 |
Synthon to accelerate investment in Biosimilars and Novel Biologicals>> |
| 22-04-10 |
Intervet/Schering-Plough animal health opens state-of-the-art vaccine manufacturing facility at biosciences center Boxmeer >> |
| 22-04-10 |
Pharming Publishes First Quarter 2010 Financial Report>> |
| 21-04-10 |
DSM Biomedical and CID Partnership Continues to Advance Device Deliverability With the Use of DSM ComfortCoat® Hydrophilic Coating >> |
| 21-04-10 |
Taiwanese interest in Leiden Bio Science Park is growing>> |
| 20-04-10 |
Hans Clevers spreekt over hoop en vrees rond stamcellen>> |
| 20-04-10 |
Qiagen drives the development of companion diagnostics with two key appointments for the new Pharma Business Development Team>> |
| 19-04-10 |
Philips' First Quarter Results 2010>> |
| 19-04-10 |
DSM announces management changes>> |
| 19-04-10 |
OctoPlus' licensee Biolex makes third presentation at EASL confirming Locteron's superior product profile>> |
| 16-04-10 |
Swedish Orphan Biovitrum And Pharming Sign Rhucin® Distribution Agreement>> |
| 16-04-10 |
Improved tolerability profile of Locteron confirmed by data presented at EASL conference>> |
| 14-04-10 |
BAC Affinity Ligand Licensed for Clinical and Commercial Scale-up of LFB Biotechnologies’ Recombinant Factor VIIa>> |
| 14-04-10 |
Aeras and Crucell Announce Start of Phase II TB study in South Africa>> |
| 13-04-10 |
Crossbeta Biosciences completes financing round and appoints Guus Scheefhals as CEO>> |
| 13-04-10 |
BioFocus launches four compound libraries targeting kinases and protein-protein interactions>> |
| 12-04-10 |
OncoMethylome Appoints Dr. Jan Groen as CEO>> |
| 12-04-10 |
OctoPlus publishes Annual Report 2009>> |
| 12-04-10 |
CCMO pleit voor minder regels bij klinisch stamcelonderzoek>> |
| 09-04-10 |
175.000 euro zoekt innovatieve ondernemers (M/V)>> |
| 08-04-10 |
Crucell Announces Release of 2009 Annual Report and Form 20-F>> |
| 08-04-10 |
De microreactoren van Chemtrix slaan aan>> |
| 08-04-10 |
Galapagos raises 2.1 million from warrant exercises, management increases shareholding>> |
| 07-04-10 |
NWO stuurt jonge onderzoekers de wijde wereld in>> |
| 07-04-10 |
Royal DSM N.V. Supervisory Board announcement>> |
| 06-04-10 |
Softenon helpt bij afwijking aan de bloedvaten>> |
| 06-04-10 |
Crucell Announces Collaboration with GlaxoSmithKline Biologicals on Second Generation Malaria Vaccine Candida >> |
| 06-04-10 |
Opening Symposium Erasmus MC Stem Cell Institute>> |
| 01-04-10 |
Drie nieuwe microfinanciering-ondernemerspunten geopend >> |
| 01-04-10 |
Three out of four cancer patients unaware of brachytherapy>> |
| 01-04-10 |
Pharming’s C1 Inhibitor Effective In Preventing AMR In Animal Model Of Transplant Rejection>> |
| 01-04-10 |
Consortium receives research grant from the Wellcome Trust to develop improved vaccines against Foot-and-Mouth Disease>> |
| 31-03-10 |
Kunstmatige alvleesklier voor diabetici>> |
| 31-03-10 |
Denise van den Berg recently joined the Mibiton Board>> |
| 31-03-10 |
"Pluk de vruchten van de gedane investeringen">> |
| 31-03-10 |
Pharming Shareholders Approve Items On EGM Agenda>> |
| 30-03-10 |
Gezondheidsfondsen geven 1 miljoen euro voor onderzoek naar bevorderen gezondere leefstijl>> |
| 30-03-10 |
Prosensa initiates clinical development of PRO044 in an open label phase I/II study>> |
| 29-03-10 |
Ronald van der Geest, PhD, joins 3D-PharmXchange>> |
| 29-03-10 |
Philips Annual General Meeting of Shareholders approves re-appointment of board members and 2010 dividend>> |
| 29-03-10 |
Notifiable Share Interest in OctoPlus N.V>> |
| 29-03-10 |
Qiagen and the University of Science and Technology of China Announce Establishment of “Qiagen Initiative Foundation Professorship”>> |
| 27-03-10 |
De hipste biotechbedrijfjes van Nederland>> |
| 25-03-10 |
Non-Executive Director appointment>> |
| 25-03-10 |
DSM Biomedical Strengthens Its Presence in the United States and Europe>> |
| 25-03-10 |
Agendia Launches BluePrint(TM) Expanding Breast Cancer Product Offering>> |
| 23-03-10 |
ZoBio is pleased to announce two new extensions to ongoing colloborations>> |
| 23-03-10 |
Millions to improve umbilical cord blood stem cell transplants>> |
| 19-03-10 |
Philips to unveil breakthrough in digital pathology>> |
| 19-03-10 |
Galapagos to build cystic fibrosis drug pipeline>> |
| 18-03-10 |
OctoPlus announces 2009 annual results meeting revenue guidance of Euro 19 million>> |
| 18-03-10 |
Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer>> |
| 17-03-10 |
Prosensa strengthens its management team>> |
| 17-03-10 |
Taaislijmziekte-patiënt minder vaak naar ziekenhuis dankzij apotheker>> |
| 16-03-10 |
NDS Surgical Imaging Launches Wireless Video Technology for the Surgical Suite>> |
| 16-03-10 |
Minister Rouvoet investeert 4,5 miljoen in Generation R>> |
| 15-03-10 |
Crucell's Supervisory Board Nominates Mr. W. Burns, Mr. J. Shannon and Mr. G. Siber as New Board Members>> |
| 15-03-10 |
Philips Simplifies Cardiology Care with Technologies That Span The Entire Spectrum Of Patient Care>> |
| 15-03-10 |
Pharming To Hold Extraordinary Shareholders’ Meeting>> |
| 12-03-10 |
Philips and ACC Address the Growing Demand for Minimally Invasive Cardiology Interventions by Showcasing Hybrid OR Solutions at ACC 2010>> |
| 12-03-10 |
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps™ and Appoints New Chief Medical Officer>> |
| 11-03-10 |
Fornix realiseert hogere nettowinst>> |
| 10-03-10 |
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B>> |
| 10-03-10 |
Crucell Appoints Jerald Sadoff MD as Chief Medical Officer>> |
| 09-03-10 |
Synthon completes acquisition of Nafar Laboratorios>> |
| 09-03-10 |
Sanofi-aventis and Merck to create a Global Leader in Animal Health>> |
| 09-03-10 |
Qiagen Extends Support of Cervical Cancer Screening Program for Underprivileged Chinese Women>> |
| 09-03-10 |
OctoPlus publishes prospectus for listing of shares issued on 18 December 2009>> |
| 08-03-10 |
DSM announces management changes>> |
| 08-03-10 |
Arcadis dochter RTKL ontwerpt groot medisch complex in Shanghai>> |
| 08-03-10 |
Philips Collaborates with Microsoft to Enhance Healthcare Efficiencies and Productivity>> |
| 05-03-10 |
SpePharm announces the acquisition of Savene® from TopoTarget, an €11 million new round of financing, and a strategic partnership with Paladin Labs, Inc>> |
| 05-03-10 |
Galapagos reports record revenues and net profit for 2009, foresees sustained profitability>> |
| 05-03-10 |
First breast cancer patients in Europe to be treated with revolutionary therapy system>> |
| 05-03-10 |
Mixture probiotics effective against constipation>> |
| 04-03-10 |
Syntarga Announces Two Antibody-Drug Conjugate Collaborations with Top-tier Biopharmaceutical Companies>> |
| 04-03-10 |
Innovation Officer regeling zorgt voor innovatieversnelling>> |
| 03-03-10 |
to-BBB and GSK to collaborate on brain delivery of a biologic product>> |
| 03-03-10 |
Nucletron appoints new vice president for Asia Pacific>> |
| 03-03-10 |
EU-geld voor onderzoek naar vaccin tegen schistosomiasis>> |
| 02-03-10 |
AmpVacs a Broadly Protective Synthetic Influenza A Vaccine>> |
| 02-03-10 |
Philips CFO updates markets on implementation of strategy to become the leading company in Health & Well-being>> |
| 01-03-10 |
NKI-AVL krijgt 4,5 miljoen van NWO>> |
| 01-03-10 |
arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development>> |
| 26-02-10 |
Nucletron and ART welcome first AccuBoost system in Europe>> |
| 26-02-10 |
Biologen en medici gaan kennis koppelen>> |
| 25-02-10 |
DSM ends 2009 with solid Q4 and very strong cash generation>> |
| 25-02-10 |
Philips strengthens sleep diagnostic portfolio through the acquisition of auto-scoring business of the Siesta Group in Austria>> |
| 25-02-10 |
Amsterdam Molecular Therapeutics Reports Full Year Results 2009>> |
| 23-02-10 |
Meer ruimte voor onderzoek kindermedicijnen>> |
| 22-02-10 |
Galapagos delivers third candidate drug in GSK alliance, receives €5.7 million.>> |
| 22-02-10 |
Ruim 8000 nieuwe innovatievouchers beschikbaar>> |
| 22-02-10 |
BAC Extends Partnership with GE Healthcare to Launch Alpha-1 Antitrypsin Select>> |
| 19-02-10 |
Crossbeta Biosciences receives innovation grant from SenterNovem>> |
| 19-02-10 |
Philips and VU Medical Center Amsterdam sign long term research agreement aimed at new multi-modality imaging solutions>> |
| 19-02-10 |
Galapagos and MorphoSys expand antibody alliance>> |
| 18-02-10 |
Pharming Announces 2009 Results >> |
| 18-02-10 |
Gen voor erfelijke oogziekte gevonden>> |
| 17-02-10 |
Pharming’s C1 Inhibitor Product Potentially Effective In Reducing Complications Following Transplantation>> |
| 17-02-10 |
BAC Extends Partnership with GE Healthcare to Launch Alpha-1 Antitrypsin Select>> |
| 17-02-10 |
Merck & Co. announces 4Q results, job cuts>> |
| 17-02-10 |
Abbott Completes Acquisition of Solvay Pharmaceuticals>> |
| 17-02-10 |
Regelgeving biotechnologie bij dieren is vereenvoudigd>> |
| 16-02-10 |
Dutch public-private partnership invests 28 million Euro on research into personalized medicine>> |
| 15-02-10 |
DSM announces management changes >> |
| 15-02-10 |
Onderzoekers ontdekken geboorteplek van bloedstamcellen>> |
| 15-02-10 |
4 miljoen euro voor onderzoek naar het afweersysteem als wapen tegen kanker>> |
| 12-02-10 |
OctoPlus announces that Locteron interim Phase IIb data have been accepted for oral and poster presentations at International Liver Congress in April>> |
| 12-02-10 |
Qiagen and Celera Establish Distribution Agreement for Respiratory Pathogen Panel>> |
| 11-02-10 |
Van der Hoeven verhoogt garantiepercentage MKB>> |
| 11-02-10 |
Biomedica brings life sciences to the Euroregion>> |
| 11-02-10 |
Abstract deadline for Immuno Valley International Conference is 15 March 2010>> |
| 10-02-10 |
Biocartis acquires Philips technology platform for automated DNA/RNA molecular diagnostic testing>> |
| 10-02-10 |
New CEO for Hoya Vision Care Europe>> |
| 10-02-10 |
Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists>> |
| 10-02-10 |
QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results>> |
| 09-02-10 |
72 miljoen euro voor Innovatiekrediet in 2010>> |
| 09-02-10 |
Crucell Announces Record Revenues and Profits for Full Year 2009>> |
| 08-02-10 |
Synthon appoints Rudy Mareel as Chief Executive Officer>> |
| 08-02-10 |
Vooruitblik FD: Crucell boekt fors lagere winst KW4 2009>> |
| 08-02-10 |
Qiagen unit and Pfizer enter into an agreement to develop a companion diagnostic for brain tumor patients>> |
| 08-02-10 |
Qiagen Acquires Exclusive Licence for Key PI3K gene>> |
| 04-02-10 |
Radboud opent oncologisch centrum>> |
| 03-02-10 |
Submission deadline for Venture Challenge is 26 March 2010>> |
| 02-02-10 |
SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market>> |
| 02-02-10 |
Galapagos acquires Argenta Discovery’s service operations>> |
| 02-02-10 |
Nieuwe kansen voor MKB internationaal>> |
| 02-02-10 |
31 Nederlandse toponderzoekers slepen Vici in de wacht>> |
| 01-02-10 |
Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines>> |
| 29-01-10 |
Merus closes EUR 21.7 million Series B financing and enters option agreement with the Novartis Option Fund>> |
| 29-01-10 |
Galapagos delivers strong 2009 performance, expects positive operating income in 2010 >> |
| 29-01-10 |
Zorginnovatieplatform maakt winnaars Call voor opschaling bekend>> |
| 28-01-10 |
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment >> |
| 28-01-10 |
Pepscan Therapeutics strengthens management team>> |
| 27-01-10 |
Patient-focused and efficient solutions drive growth of Philips Healthcare in the Middle East>> |
| 27-01-10 |
Patenten opgeheven in strijd tegen malaria>> |
| 26-01-10 |
Veerman Committee argues for continuation of TI Pharma>> |
| 26-01-10 |
Fornix publiceert voorlopige resultaten 2009>> |
| 26-01-10 |
QIAGEN Launches New Instrument to Enhance Laboratory Workflow >> |
| 25-01-10 |
Philips reports fourth-quarter sales of EUR 7.3 billion and EBITA of EUR 662 million>> |
| 25-01-10 |
EMA starts formal review of Glybera® dossier>> |
| 25-01-10 |
Farmabedrijven helpen Haïti>> |
| 25-01-10 |
EMA Starts Formal Review of Glybera(R) Dossier>> |
| 22-01-10 |
Gratis voorlichtingsworkshops WBSO>> |
| 22-01-10 |
Pharming Gives Update On Rhucin EU Marketing Authorization Application>> |
| 22-01-10 |
BMEYE Receives CE Mark to Launch First Noninvasive Cardiovascular Monitor with Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Technology in Europe>> |
| 21-01-10 |
Prijs van 2,2 miljoen euro voor viroloog Osterhaus>> |
| 21-01-10 |
Successful completion of Cord Blood expansion project between Cryo-Save and Etablissement Francais Du Sang, France. >> |
| 21-01-10 |
Nieuw octrooiregister NL Octrooicentrum>> |
| 21-01-10 |
De Jager: Belastingdienst biedt hulp bij innovatievragen >> |
| 20-01-10 |
Europese miljoenen voor twee Wageningse onderzoekers>> |
| 20-01-10 |
Philips and Smit Mobile Equipment present solution for mobile breast cancer screening at Arab Health 2010>> |
| 20-01-10 |
Dutch biotech rising in world rankings>> |
| 19-01-10 |
Galapagos candidate metastasis drug shows good safety and biomarker response >> |
| 19-01-10 |
Nieuwe DNA-varianten voor risico op diabetes type 2>> |
| 19-01-10 |
Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer>> |
| 18-01-10 |
Masterclass BioBusiness in april 2010 van start>> |
| 15-01-10 |
Galapagos achieves milestones in strategic alliances with Merck & Co., Inc. >> |
| 15-01-10 |
TOP-subsidie NWO voor Leids onderzoek naar papillomavirus >> |
| 14-01-10 |
IB-ondernemer kan wel degelijk profiteren van innovatiebox>> |
| 13-01-10 |
Life Sciences Pre-Seed Grant: Call open for submissions>> |
| 12-01-10 |
Galapagos service division achieves €1.6 M in payments >> |
| 12-01-10 |
FABPulous B.V. closes first financing round>> |
| 12-01-10 |
Pharming Provides Business Update>> |
| 12-01-10 |
QIAGEN Acquires ESE GmbH>> |
| 11-01-10 |
ViroPharma Expands Global Licensing, Commercialization and Development Rights for Cinryze(TM) (C1 esterase inhibitor [human])>> |
| 11-01-10 |
AMT submits its lead product Glybera® Application for Marketing Authorisation Application to EMA >> |
| 11-01-10 |
Galapagos and Roche initiate strategic alliance in COPD>> |
| 08-01-10 |
to-BBB announces two additional pharma collaborations on brain drug delivery>> |
| 07-01-10 |
ProFibrix obtains government loan of up to EUR 5 million (~ US$7.4 million) to support clinical development of its lead hemostasis product Fibrocaps™ >> |
| 07-01-10 |
Philips and bioMérieux announce partnership to develop and market next-generation handheld diagnostic solutions for point-of-care>> |
| 07-01-10 |
Skyline Diagnostics raises EUR 5 million in Series B financing>> |
| 07-01-10 |
OncoMethylome Sciences to Perform MGMT Testing in Roche Phase III Study of Avastin for Glioblastoma>> |
| 06-01-10 |
AMT Receives Innovation Credit from Dutch Government for Duchenne Muscular Dystrophy >> |
| 06-01-10 |
Mibiton Science: versterking van samenwerking tussen ondernemende onderzoekers en het bedrijfsleven.>> |
| 05-01-10 |
Pharming Obtains Euro 7.5 Million Financing>> |
| 29-12-09 |
AM-Pharma announces positive results from its Acute Kidney Injury trial>> |
| 23-12-09 |
DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler>> |
| 23-12-09 |
"Nederland loopt voorop bij stamcelonderzoek">> |
| 22-12-09 |
Update: Euro 81 million for life sciences & health sector in The Netherlands>> |
| 22-12-09 |
45 miljoen voor kenniswerkers>> |
| 22-12-09 |
Grant for stem cell and tissue engineering technology>> |
| 22-12-09 |
to-BBB and Lundbeck to join forces on brain delivery of antibodies for CNS diseases>> |
| 22-12-09 |
Research: dosage of morphine for ill newborns still too imprecise>> |
| 21-12-09 |
81 miljoen voor life sciences & health sector >> |
| 21-12-09 |
Impuls van 350 miljoen euro voor Nederlandse kennis en vernieuwing>> |
| 18-12-09 |
OctoPlus announces successful equity raising of € 4 million to strengthen its financial position>> |
| 18-12-09 |
Belangrijke tekortkomingen PROPATRIA-studie, verbeteringen voor verantwoord klinisch onderzoek noodzakelijk>> |
| 17-12-09 |
FDA Broadens Clearance for Agendia’s MammaPrint®>> |
| 17-12-09 |
Galapagos and GlaxoSmithKline broaden arthritis alliance>> |
| 17-12-09 |
TNO steps into microdosing>> |
| 16-12-09 |
Avantium Appoints Gunnar Staaf as CEO Pharma>> |
| 16-12-09 |
Amsterdam Molecular Therapeutics (AMT) successfully raises EUR 5 million via a Convertible Bond issue with shareholder Forbion>> |
| 16-12-09 |
ProteoNic and Novozymes Sign Agreement for UNic™ yield enhancer>> |
| 14-12-09 |
QIAGEN Announces Closing of the Acquisition of SABiosciences>> |
| 11-12-09 |
Join Life Sciences & Health on LinkedIn>> |
| 11-12-09 |
Leiden Bio Science Park ontvangt Mibiton kwaliteitscertificaat>> |
| 10-12-09 |
Pluriomics wins the NGI Venture Challenge Fall 2009>> |
| 10-12-09 |
177 extra publieke innovatievouchers beschikbaar>> |
| 10-12-09 |
Nieuwe voorzitter lanceert Mibiton Science fonds>> |
| 10-12-09 |
Onderzoeksprogramma ‘Photonic Devices’ krijgt vervolg tot 2015>> |
| 10-12-09 |
Cryo-Save welcomes new proposed French Law supporting Cord Blood banking>> |
| 09-12-09 |
Pharming Confirms Interaction With US FDA For Rhucin>> |
| 09-12-09 |
DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits>> |
| 09-12-09 |
Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium>> |
| 08-12-09 |
Galapagos receives €4 M milestone for first clinical trial in GlaxoSmithKline alliance>> |
| 08-12-09 |
Nucletron Appoints Robert Fenwick VP of External Beam >> |
| 08-12-09 |
Philips CEO updates market on implementation of strategy to become the leading company in Health & Well-being >> |
| 07-12-09 |
Nederland in kopgroep Europees technologisch onderzoek>> |
| 07-12-09 |
Galapagos CEO increases shareholding>> |
| 07-12-09 |
Synthon announces TGA approval for Letrozole>> |
| 04-12-09 |
Galapagos achieves multiple milestones in rheumatoid arthritis alliance>> |
| 03-12-09 |
arGEN-X concludes EUR 12.5 million Series A financing round>> |
| 03-12-09 |
Dutch biotech company Pepscan appoints new CEO>> |
| 03-12-09 |
TET Systems and AMC/STW Enter into an Assignment Agreement>> |
| 02-12-09 |
European Investment Bank and Philips sign EUR 200 million healthcare R&D loan agreement>> |
| 02-12-09 |
AMT Announces Management Changes in light of refocused strategy>> |
| 02-12-09 |
Aanvragen zorginnovatievouchers mogelijk tot 31 december 2009>> |
| 02-12-09 |
Medicare Administrator Establishes Reimbursement Coding Policy for Agendia’s Breast Cancer Recurrence Test MammaPrint®>> |
| 01-12-09 |
Lead Pharma opent nieuwe vestiging in ‘Kraamkamer’ UMC St Radboud>> |
| 01-12-09 |
Prof.dr. P. Heutink ontvangt Wetenschapsprijs van € 1 miljoen voor Parkinson>> |
| 30-11-09 |
Kiadis Pharma announces enrollment of first patients in a multinational registration study for ATIR™>> |
| 30-11-09 |
Elsevier Is Re-Launching "Embase" To Be A Powerful Resource Provising Deep Insights And Answers To Biomedical Researchers >> |
| 27-11-09 |
Philips helps hospitals strike balance between innovation and value>> |
| 27-11-09 |
Philips agrees to sell FIMI to Barco of Belgium>> |
| 26-11-09 |
Nederland presteert goed in Zevende Kaderprogramma>> |
| 26-11-09 |
Galapagos receives EUREKA innovation label and OSEO funding>> |
| 25-11-09 |
iThemba Pharmaceuticals Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering>> |
| 25-11-09 |
89 onderzoekers zien zonnige toekomst tegemoet>> |
| 25-11-09 |
Uppsala Academic Hospital Chooses Nucletron’s Oncentra® VMAT as Treatment Planning Solution >> |
| 24-11-09 |
Design team selected for new HollandPTC proton therapy clinic>> |
| 23-11-09 |
Drie Nederlandse toponderzoekers presenteren plan om migraine te lijf te gaan>> |
| 20-11-09 |
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA®>> |
| 19-11-09 |
Met een navelstreng leukemie te lijf>> |
| 18-11-09 |
Galapagos initiates Nanocort® Phase II clinical trial for multiple sclerosis>> |
| 18-11-09 |
AMT Provides Business Update for the Third Quarter 2009>> |
| 17-11-09 |
New consortium paves the way for improved treatment of hypertension>> |
| 16-11-09 |
Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation>> |
| 16-11-09 |
Nederlands Life Sciences mkb scoort wederom goed in call EuroTransBio>> |
| 13-11-09 |
Galapagos business update>> |
| 12-11-09 |
PanGenetics announces acquisition by Abbott of PG110 anti-NGF antibody to treat chronic pain>> |
| 12-11-09 |
Dyadic Netherlands Joins Kluyver Centre’s Industrial Platform>> |
| 11-11-09 |
Elf miljoen euro voor transplantatie bij diabetes type 1>> |
| 11-11-09 |
AMT Successful in Preclinical Treatment of DMD>> |
| 11-11-09 |
SenterNovem per 1 januari 2010 onderdeel van Agentschap NL>> |
| 10-11-09 |
arGEN-X opens new R&D facility in Flanders>> |
| 10-11-09 |
Doorbraak biotechbedrijf ISA met kankertherapie >> |
| 10-11-09 |
QIAGEN to Acquire SABiosciences>> |
| 10-11-09 |
QIAGEN Reports Strong Third Quarter 2009 Results >> |
| 09-11-09 |
TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services>> |
| 09-11-09 |
OctoPlus publishes third quarter business update>> |
| 09-11-09 |
Niaba-symposium: Franse stimuleringsmaatregelen voor de biotechnologie-industrie>> |
| 06-11-09 |
arGEN-X is awarded €1.3 million grant for the development of its novel SIMPLE Antibody™ Platform>> |
| 06-11-09 |
Nieuwe structuur donorvertegenwoordiging bij Sanquin>> |
| 06-11-09 |
PharmaCell BV appoints new CEO>> |
| 06-11-09 |
DSM Pharmaceutical Products forms manufacturing alliance with Galenix >> |
| 05-11-09 |
ISA Pharmaceuticals announces NEJM publication on VIN phase II data>> |
| 05-11-09 |
QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing>> |
| 05-11-09 |
Promising clinical data from Kiadis Pharma’s lead product ATIR™ will be presented at the 51st American Society of Hematology’s (ASH) Annual Meeting>> |
| 05-11-09 |
Fornix publishes nine months' trading update 2009>> |
| 05-11-09 |
Fornix kosten dalen in 1e9MND, omzet staat onder druk >> |
| 04-11-09 |
New Merck Begins Operations>> |
| 04-11-09 |
Philips and largest Dutch healthcare insurer partner to increase patient independence at home>> |
| 04-11-09 |
to-BBB announces collaboration with Genzyme on brain delivery of biologics for neurodegenerative diseases >> |
| 04-11-09 |
Life Sciences Center Amsterdam granted EFRO subsidy>> |
| 03-11-09 |
Merck and Schering-Plough to Complete Merger Today>> |
| 03-11-09 |
Crucell Announces Third Quarter 2009 Results>> |
| 03-11-09 |
Bicycle Therapeutics and Pepscan enter into partnership to apply constrained peptide technology in the development of novel biotherapeutics>> |
| 03-11-09 |
DSM delivers strong result improvement in Q3 >> |
| 02-11-09 |
BAC BV expands alliance with Octapharma Group for the purification of recombinant proteins>> |
| 02-11-09 |
InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways>> |
| 02-11-09 |
Protonentherapie uitdaging voor radiotherapie in Nederland>> |
| 30-10-09 |
Philips led HYPERImage project advances research on hybrid PET/MR scanner>> |
| 29-10-09 |
AMT Starts Development LPLChip(TM) with Progenika>> |
| 28-10-09 |
Overzicht regelingen en subsidies voor ondernemers>> |
| 28-10-09 |
Pharming To Present At BIO-europe 2009>> |
| 28-10-09 |
DSM Unveils VitroStealth™ Coating Technology>> |
| 27-10-09 |
Crucell to Release Q3 2009 Results on Tuesday November 3, 2009>> |
| 27-10-09 |
DSM PTG Unveils Bionate® II PCU>> |
| 27-10-09 |
NOTOX collaboration with Semler Research Center in India>> |
| 26-10-09 |
Merck and Schering-Plough Receive Approval From European Commission for Merger >> |
| 23-10-09 |
Corvitex and to-BBB join forces to raise funds in the USA>> |
| 23-10-09 |
Pharming Recombinant Human C1 Inhibitor: Results In Pre-clinical Ischaemic Reperfusion Model Confirm Potential For New Indications>> |
| 22-10-09 |
Admission to trading on Euronext for Cryo-Save>> |
| 21-10-09 |
Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris>> |
| 21-10-09 |
VIRGO Consortium wins €1 million NGI Valorisation Award 2009>> |
| 21-10-09 |
Biotech vraagt om onderzoeksgeld voor langere termijn>> |
| 21-10-09 |
A vision for the life sciences in the Netherlands >> |
| 20-10-09 |
Volop bedrijvigheid in biotechsector door startkapitaal>> |
| 20-10-09 |
Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA Conference>> |
| 16-10-09 |
Pharming Announces Third Quarter 2009 Results>> |
| 16-10-09 |
Alle vouchers voor 2009 uitgegeven>> |
| 16-10-09 |
Galapagos successfully completes placement of 2,125,925 new ordinary shares>> |
| 14-10-09 |
Nobilon Advances Intranasal Seasonal Influenza Vaccine Into Proof of Concept Study >> |
| 14-10-09 |
Philips introduces an intelligent sleep therapy system to treat a common sleep disorder: Obstructive Sleep Apnea>> |
| 14-10-09 |
Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc>> |
| 14-10-09 |
Pharming Confirms Successful Closing Of Offer On Convertible Bonds>> |
| 13-10-09 |
Prosensa and GlaxoSmithKline form alliance to fight Duchenne Muscular Dystrophy>> |
| 13-10-09 |
AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy>> |
| 12-10-09 |
Santarus and Norgine enter license for ZEGERID immediate-release omeprazole products in Europe>> |
| 12-10-09 |
Call for proposals for Marie Curie European Re-integration Grants published>> |
| 12-10-09 |
Nucletron partners with Docrates Clinic to bring new cancer treatment to Finland>> |
| 12-10-09 |
Philips brings the digital revolution to the pathology laboratory>> |
| 09-10-09 |
Leiden Bio Science Park best businesspark 2009>> |
| 09-10-09 |
BMEYE B.V. completes € 6 million Series B financing round >> |
| 08-10-09 |
Philips announces breakthrough in fully digital light detection technology>> |
| 08-10-09 |
Pharming Finalizes Conversion Of 70% Of Outstanding Bonds - more info>> |
| 07-10-09 |
Galapagos achieves first milestone in anti-infectives alliance with GlaxoSmithKline>> |
| 06-10-09 |
KeyGene establishes Crop Genome Center>> |
| 05-10-09 |
Pharming Secures Additional € 10 Million Financing From Yorkville Advisors>> |
| 02-10-09 |
LSH initiates a consortium for access to the Thomson Pharma database>> |
| 30-09-09 |
ORCA Therapeutics licenses oncolytic adenovirus technology from VCN Biosciences >> |
| 30-09-09 |
Prosensa and LUMC strengthen strategic alliance through broadened RNA modulation license agreement>> |
| 30-09-09 |
Crucell Strengthens its Vaccine Sales in the UK with a Dedicated Marketing and Sales Organization >> |
| 30-09-09 |
Nucletron Announces the First U.S. Patient Treatment with the Flexitron Brachytherapy Treatment Delivery Solution at the Cancer Specialists of Oklahoma Cancer Center>> |
| 30-09-09 |
Pharming Receives Commitment For Conversion Of 70% Of Outstanding Bonds>> |
| 29-09-09 |
Trade trip to Denmark for the Medical Biotechnology Industry>> |
| 29-09-09 |
Nucletron and Isodose Control announce cooperation>> |
| 28-09-09 |
Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment >> |
| 25-09-09 |
Agendia raises US $23 million in series E financing >> |
| 25-09-09 |
OctoPlus announces further efficiency measures>> |
| 24-09-09 |
AMT Appoints New Chief Executive Officer>> |
| 23-09-09 |
QIAGEN Acquires DxS Ltd – Creating Leadership in Personalized Healthcare>> |
| 23-09-09 |
Philips and Celsion Advance Development of ThermoDox(R) and MR-Guided HIFU>> |
| 23-09-09 |
Pharming's Marketing Authorisation Application For Rhucin Validated By The European Medicines Agency (EMEA)>> |
| 23-09-09 |
Philips and Bruker BioSpin sign memorandum of understanding to bring new imaging technology to the preclinical market>> |
| 22-09-09 |
Mucosis receives key US patent covering its MIMOPATH ™ technology>> |
| 21-09-09 |
20 miljoen voor hersen- en cognitieonderzoek>> |
| 21-09-09 |
Pharming Announces Offer To Holders Of Convertible Bonds With Financial Support Of Current Shareholders >> |
| 18-09-09 |
Pharming To Present At UBS Global Life Sciences Conference>> |
| 18-09-09 |
METC's strenger aan termijnen gebonden>> |
| 17-09-09 |
Nieuw programma Gezondheidszorgonderzoek>> |
| 17-09-09 |
DSM Biomedical develops polymer platform for artificial hips and knees >> |
| 17-09-09 |
Prosensa’s RNA based therapeutic PRO051 shows favourable results in the first systemic study in patients with Duchenne muscular dystrophy >> |
| 17-09-09 |
Synthon announces European approvals for Raloxifene >> |
| 17-09-09 |
to-BBB technology will be used by MedImmune to evaluate >> |
| 16-09-09 |
Life Sciences & Health newsletter >> |
| 16-09-09 |
DNage Initiates Observational Study In Children Suffering From Cockayne Syndrome>> |
| 15-09-09 |
Findings from 52-week study presented at major European psychiatry congress demonstrate time to relapse significantly longer with SAPHRIS>> |
| 14-09-09 |
OctoPlus signs service contract with Axentis Pharma>> |
| 14-09-09 |
Duurzaamheidscan voor MKB-ondernemers >> |
| 14-09-09 |
Een boekje vol goede voorbeelden >> |
| 11-09-09 |
500 nieuwe 'private innovatievouchers' beschikbaar>> |
| 10-09-09 |
QIAGEN Releases New Pandemic Influenza A/H1N1 Detection Kit>> |
| 10-09-09 |
arGEN-X raises €9.5 million to put SIMPLE Antibody™ platform to work>> |
| 08-09-09 |
OctoPlus wins expansion of drug delivery evaluation contract with existing client>> |
| 04-09-09 |
135 miljoen verdeeld voor kenniswerkers>> |
| 03-09-09 |
Nucletron increases full year outlook after strong first half 2009 >> |
| 03-09-09 |
Pharming Submits Marketing Authorisation Application For Rhucin® To The EMEA>> |
| 01-09-09 |
Acht miljoen voor verspreiding innovaties in zorgsector>> |
| 30-07-09 |
Seventh Framework calls for Life Sciences opened>> |
| 24-07-09 |
NGI Venture challenge Fall 2009 is open for application!>> |
| 20-07-09 |
Call for collaborative research projects in nanomedicine closes September 1st>> |
| 17-06-09 |
280 miljoen euro voor crisismaatregelen voor innovatie>> |
| 09-06-09 |
Five Dutch institutes in European top 20 for research in clinical medicine>> |
| 09-06-09 |
FD: "Merck onderzoekt verkoop van Intervet">> |
| 08-06-09 |
Professor Julia Kirchheiner wins the Utrecht Award for Excellence in Pharmaceutical Research>> |
| 15-05-09 |
FD: "Groot en klein in Nederlandse 'life sciences' sluiten eindelijk de rijen">> |
| 13-05-09 |
FD: "Medische sector in bedrijf">> |
| 07-05-09 |
New Website Launched>> |
